Skip to Content

Measles, Mumps, Rubella and Varicella Virus Vaccine Live Injection, ProQuad

Last Updated: November 14, 2012
Status: Resolved

Products Affected - Description

There are no presentations affected.

Reason for the Shortage

  • Merck cannot provide a reason for the shortage.1
  • Merck is the sole manufacturer of this combination product.

Available Products

ProQuad single dose vials (NDC 00006-4999-00), Merck

Estimated Resupply Dates

Merck has ProQuad available.1

Implications for Patient Care

ProQuad is used to simultaneously vaccinate children 12 months to 12 years of age against measles, mumps, rubella, and varicella.2

Safety

Do not mix MMR-II and Varivax in the same syringe during this shortage.2

Alternative Agents & Management

Clinicians must use the single component vaccines MMR-II and Varivax during this shortage.1

Related Shortages

References

  1. Merck, (personal communication).  February 26, March 5, May 29, July 10 and 23, 2007; February 11, August 18, 2008; February 11, June 1, June 23, September 1, November 30, 2009; January 21, February 3, March 26, May 4 and 10, June 14, July 26, August 11, September 10, September 22, 2010; March 14, June 7, August 30,  October 14, and December 12, 2011; February 8, April 10, June 29, August 29, October 2, and November 14, 2012.
  2. ProQuad (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live) [product information]. West Point, PA:  Merck; 2006, July.

Updated

Updated November 14, 2012 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 6, 2007 by Erin R. Fox, PharmD, Drug Information Specialist. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide